ARCHIVES

“Whatever Happened To…?” ACS Follows Up Five Years Later

This article is from The Cancer Letter archive.

Vol. 03 No. 34 | August 26, 1977

Download PDF Visit The Full Archive

Related Articles

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

March 21, 1986

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

NCI Starts $2 Million Study On Cancer Patient Job Discrimination

January 17, 1975

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

December 11, 1987

NCI-Approved Clinical Trials Listed For January

January 28, 2005

Foundation Honors Three In Oncology; Society Wins Software Grant From Microsoft.

October 26, 2001